Approval · Notice of Compliance 4051 · 1997
REQUIP: Notice of Compliance 4051
Issued August 19, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4051
- Date
- August 19, 1997
- Company
- Smithkline Beecham Pharma, Division Of Smithkline Beecham Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antiparkinsonian agent
Products in this notice
Medicinal ingredients
- ROPINIROLE HYDROCHLORIDE 0.25 MG per TAB
- ROPINIROLE 0.5 MG per TAB
- ROPINIROLE 1 MG per TAB
- ROPINIROLE 2 MG per TAB
- ROPINIROLE 5 MG per TAB